ATE513823T1 - Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung - Google Patents

Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung

Info

Publication number
ATE513823T1
ATE513823T1 AT04254939T AT04254939T ATE513823T1 AT E513823 T1 ATE513823 T1 AT E513823T1 AT 04254939 T AT04254939 T AT 04254939T AT 04254939 T AT04254939 T AT 04254939T AT E513823 T1 ATE513823 T1 AT E513823T1
Authority
AT
Austria
Prior art keywords
compound
relates
present
antrodia camphorata
mixture
Prior art date
Application number
AT04254939T
Other languages
English (en)
Inventor
Massao Hattori
Chia-Chin Sheu
Original Assignee
Simpson Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simpson Biotech Co Ltd filed Critical Simpson Biotech Co Ltd
Application granted granted Critical
Publication of ATE513823T1 publication Critical patent/ATE513823T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04254939T 2004-08-17 2004-08-17 Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung ATE513823T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04254939A EP1634877B1 (de) 2004-08-17 2004-08-17 Mischung und Verbindungen von Mycelien von Antrodia Camphorata und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE513823T1 true ATE513823T1 (de) 2011-07-15

Family

ID=34930575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04254939T ATE513823T1 (de) 2004-08-17 2004-08-17 Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung

Country Status (3)

Country Link
US (4) US7763723B2 (de)
EP (1) EP1634877B1 (de)
AT (1) ATE513823T1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005527198A (ja) 2002-02-14 2005-09-15 シティ・オブ・ホープ 哺乳動物細胞において、干渉ｒｎａ分子を産生する方法、および該干渉ｒｎａ分子の療法的使用
US8648113B2 (en) * 2004-03-08 2014-02-11 Simpson Biotech Co., Ltd. Mixture and compounds from mycelia of Antrodia camphorata and use thereof
US20100324309A1 (en) * 2008-04-09 2010-12-23 Simpson Biotech Co., Ltd. Novel Mixture and Compounds from Mycelia of Antrodia Camphorata and Use Thereof
TWI426916B (zh) * 2006-10-17 2014-02-21 Simpson Biotech Co Ltd 具有護肝功效之樟芝多醣體
CN101553238A (zh) * 2006-10-23 2009-10-07 善笙生物科技股份有限公司 具有保肝作用的组合物
TWI448294B (zh) 2009-03-04 2014-08-11 高雄醫學大學 增強免疫活性之樟芝子實體水萃取物及其製備方法
EP2329816B1 (de) 2009-11-26 2016-04-13 National Taiwan University Antikrebs-Wirkstoff aus Antrodia camphorata, Herstellungsverfahren und Verwendung dafür
US20110150856A1 (en) * 2009-12-21 2011-06-23 Sarah Bacus Compositions and methods for treatment of vitiligo
CA2796459C (en) 2010-04-16 2016-05-24 Salk Institute For Biological Studies Methods for treating metabolic disorders using fgf-1
TWI452032B (zh) * 2011-01-21 2014-09-11 國鼎生物科技股份有限公司 治療腎病之醫藥組成物
TW201231474A (en) * 2011-01-26 2012-08-01 Univ Kaohsiung Medical Triterpenoid composition of Antrodia cinnamomea, preparation and analysis method thereof
US20130128908A1 (en) 2011-11-18 2013-05-23 Laser Energetics Inc. Diode pumped solid state opto-mechanically optimized green laser
CN102495167A (zh) * 2011-12-09 2012-06-13 劲牌有限公司 枸杞多糖提取物中枸杞多糖的检测方法
TWI425948B (zh) * 2012-01-20 2014-02-11 優生生物科技股份有限公司 Compositions for the inhibition or killing of Porphyromonas gingivalis and their use for the alleviation or treatment of periodontal disease and other diseases
TWI522112B (zh) * 2012-12-11 2016-02-21 財團法人工業技術研究院 疫苗佐劑、疫苗組合物與牛樟芝子實體之多醣體用於製備一疫苗佐劑的用途
US9480723B2 (en) * 2013-05-02 2016-11-01 Kingland Property Corporation, Ltd. Method of preparing an extract of Antrodia cinnamomea having an elevated antcin C and zhankuic C content
WO2015061331A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
WO2015061361A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Mutated fibroblast growth factor (fgf) 1 and methods of use
CN104546830B (zh) * 2013-10-23 2018-03-09 善笙生物科技股份有限公司 来自牛樟芝菌丝体的化合物及混合物的用途
TW201521752A (zh) * 2013-12-05 2015-06-16 國立臺灣師範大學 牛樟芝於抗肥胖的應用及其方法
WO2016006733A1 (ko) * 2014-07-09 2016-01-14 강원대학교산학협력단 섬유모세포성장인자 유래의 펩타이드 단편을 포함하는 상처 치료 또는 피부 주름형성 억제용 조성물
CN104072631A (zh) * 2014-07-15 2014-10-01 江苏阜丰生物科技有限公司 一种高效提取深层液态发酵生产樟芝菌丝体多糖的方法
US9884801B2 (en) 2014-12-30 2018-02-06 Oneness Biotech Co., Ltd. Compounds from antrodia camphorata, method for preparing the same and use thereof
EP3061767A1 (de) * 2015-02-25 2016-08-31 Infinitec Activos, S.L. Neue dodekapeptide und mikrokapseln, die mit ihnen funktionalisiert sind, mit abzielung auf fibroblasten
EP3285793A4 (de) * 2015-04-20 2018-10-10 Salk Institute for Biological Studies Mutanten des fibroblasten-wachstumsfaktors (fgf) 1 und verfahren zur verwendung zur verringerung der blutglukose
JP2018535964A (ja) 2015-10-30 2018-12-06 ソーク インスティテュート フォー バイオロジカル スタディーズ 線維芽細胞増殖因子（ｆｇｆ）１アナログによるステロイド誘導性高血糖の処置
US10385113B2 (en) 2016-03-30 2019-08-20 The Board Of Trustees Of The University Of Arkansas Engineered FGF compositions and methods of use thereof
CN106699918B (zh) * 2017-01-13 2019-01-29 四川大学 野阳合多糖及其制备方法和应用
US11479591B2 (en) * 2017-05-05 2022-10-25 Trefoil Therapeutics, Inc. Recombinant modified fibroblast growth factors and therapeutic uses thereof
US11267855B2 (en) 2018-03-16 2022-03-08 The Board Of Trustees Of The University Of Arkansas Engineered FGF1 and FGF2 compositions and methods of use thereof
CN113795258B (zh) * 2019-02-25 2024-04-16 吉亚生技控股股份有限公司 抑制病毒感染的方法及组合物
CN112076187B (zh) 2019-06-12 2022-04-08 善笙生物科技股份有限公司 安卓锭在制备用于预防或治疗非酒精性脂肪肝的药物中的用途
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
EP3845555A1 (de) * 2019-12-31 2021-07-07 Algaeprona Inc. Vektor zur herstellung und expression von menschlichem wachstumsfaktor und mit dem vektor transformierte mikroalgen
WO2021218974A1 (en) * 2020-04-28 2021-11-04 Alps Biotech Co., Ltd. Uses of antrodia cinnamomea extract in manufacturing products for reducing expression and treating associated diseases of angiotensin converting enzyme 2
CN119320462B (zh) * 2024-10-29 2025-11-18 中国科学院昆明植物研究所 茶果樟多糖及其提取方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560464A (en) * 1978-01-09 1980-02-06 Inst Tonkoi Organic Khim Im A Anticonvulsant
US4188398A (en) * 1978-02-06 1980-02-12 Akopian Nina E Method for treating epilepsy
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor
US5223483A (en) * 1987-10-22 1993-06-29 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5750365A (en) * 1993-05-28 1998-05-12 The Ohio State University Research Foundation Isolated nucleic acid encoding a newt acidic fibroblast growth factor (AFGF)
AU771904B2 (en) * 1999-06-22 2004-04-08 Research Development Foundation Enhanced wound coverage to enhance wound healing
AU784122B2 (en) * 1999-12-29 2006-02-09 Boris Khaimovich Strelets Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
US6767543B2 (en) * 2000-02-17 2004-07-27 Council Of Agriculture, Executive Yuan Process for producing a culture of Antrodia camphorata and product obtained thereby
US6558943B1 (en) * 2000-09-05 2003-05-06 Sun Ten Pharmaceutical Co., Ltd. Method for propagating fungi using solid state fermentation
CN1192098C (zh) * 2000-11-13 2005-03-09 葡萄王企业股份有限公司 樟芝菌丝体生物活性物质其制备法及含其组成物
CN1386545A (zh) * 2001-05-18 2002-12-25 葡萄王企业股份有限公司 樟芝保肝制剂
US6740517B2 (en) * 2001-12-14 2004-05-25 Ming-Huang Lan Incubation method for obtaining solid culture of Zang Zhi, solid culture obtained therefrom, processed products and use thereof
GB0316232D0 (en) * 2003-07-11 2003-08-13 Astrazeneca Ab Therapeutic agents
US7109232B2 (en) * 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity

Also Published As

Publication number Publication date
EP1634877B1 (de) 2011-06-22
US20060089402A1 (en) 2006-04-27
EP1634877A1 (de) 2006-03-15
US20090048330A1 (en) 2009-02-19
US7732482B2 (en) 2010-06-08
US7763723B2 (en) 2010-07-27
US20060217310A1 (en) 2006-09-28
US20060052337A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
US7230017B2 (en) Dihydropyridinone derivatives
US5973188A (en) Acetic acid derivatives
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
DK0747374T3 (da) Sulfonamidsubstituerede benzopyraner som kaliumkanalaktivatorer
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
BRPI0605934A2 (pt) processos para a preparação de ( 3r, 4s) - 4 - ( (4-benziloxi ) fenil ) - 1 - ( 4 - fluorofenil ) - 3 - ( (s) - 3 - ( 4 - fluorofenil ) - 3 - hidroxipropil) - 2 - azetidinona, um intermediário para a sìntese da ezetimiba
DE69623745D1 (de) Derivate von DC 107
BRPI0406721A (pt) Compostos condensados de furano
IL155965A0 (en) Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
MX2007004637A (es) Sintesis asimetrica de derivados de dihidrobenzofurano.
WO2005080372A1 (en) Dihydropyridinone derivatives
CA2256438C (en) Aromatic amidine derivatives useful as selective thrombin inhibitors
DK1018511T3 (da) Isochromanforbindelser og fremgangsmåde til deres fremstilling
ATE259376T1 (de) Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren
NO20002589L (no) Bifenylamidinderivater
IL175940A0 (en) Prostaglandin synthesis
WO2004071428A3 (en) 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
SI2161260T1 (sl) Polsintezni postopek za pripravo 10-deacetil-n-debenzoil-paklitaksela
CA2676424A1 (en) Taxane derivatives and processes for the preparation thereof
FI60705C (fi) Foerfarande foer framstaellning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-3,5-pyridinkarboxylsyraisopropyl-(2-propoxi-etyl)-ester som anvaendes som perifer vasodilatator
DE60028475D1 (de) Stabilisatormischung
IL141394A0 (en) Process for the preparation of imidazodiazepine intermediates
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
DE69909098D1 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties